Dr. Mitchell Lazar is the Sylvan Eisman Professor of Medicine and Genetics, the Chief of the Division of Endocrinology, Diabetes, and Metabolism, and the Director of the Institute for Diabetes, Obesity, and Metabolism at the University of Pennsylvania. He received his undergraduate degree in Chemistry from MIT, a PhD in Neurosciences and an MD from Stanford University. He trained in Internal Medicine at Brigham and Women’s Hospital and in Endocrinology at the Massachusetts General Hospital before joining the University of Pennsylvania faculty in 1989. Dr. Lazar's identification of the nuclear heme receptor Rev-erba and its corepressor complex, and his pioneering studies of PPARg including discovery of the adipocyte hormone resistin, have linked basic mechanisms of gene transcription to physiology and metabolic diseases. He has been elected to the American Society for Clinical Investigation and the Association of American Physicians, to the Institute of Medicine of the National Academy of Sciences in 2006, and to the American Academy of Arts and Sciences in 2008.
« Go Back